Annexin-A1 enhances breast cancer growth and migration by promoting alternative macrophage polarization in the tumour microenvironment

Macrophages are potent immune cells with well-established roles in the response to stress, injury, infection and inflammation. The classically activated macrophages (M1) are induced by lipopolysaccharide (LPS) and express a wide range of pro-inflammatory genes. M2 macrophages are induced by T helper type 2 cytokines such as interleukin-4 (IL4) and express high levels of anti-inflammatory and tissue repair genes. The strong association between macrophages and tumour cells as well as the high incidences of leukocyte infiltration in solid tumours have contributed to the discovery that tumour-associated macrophages (TAMs) are key to tumour progression. Here, we investigated the role of Annexin A1 (ANXA1), a well characterized immunomodulatory protein on macrophage polarization and the interaction between macrophages and breast cancer cells. Our results demonstrate that ANXA1 regulates macrophage polarization and activation. ANXA1 can act dually as an endogenous signalling molecule or as a secreted mediator which acts via its receptor, FPR2, to promote macrophage polarization. Furthermore, ANXA1 deficient mice exhibit reduced tumour growth and enhanced survival in vivo, possibly due to increased M1 macrophages within the tumor microenvironment. These results provide new insights into the molecular mechanisms of macrophage polarization with therapeutic potential to suppress breast cancer growth and metastasis.

[1]  L. Zitvogel,et al.  In vivo veritas , 2005, Nature Biotechnology.

[2]  E. Tajara,et al.  Inflammation and Cancer: Role of Annexin A1 and FPR2/ALX in Proliferation and Metastasis in Human Laryngeal Squamous Cell Carcinoma , 2014, PloS one.

[3]  Ming-Rong Wang,et al.  Three isoforms of annexin I are preferentially expressed in normal esophageal epithelia but down-regulated in esophageal squamous cell carcinomas , 2002, Oncogene.

[4]  Xiaojing Ma,et al.  A novel role of hematopoietic CCL5 in promoting triple-negative mammary tumor progression by regulating generation of myeloid-derived suppressor cells , 2012, Cell Research.

[5]  F. D’Acquisto,et al.  Annexin A1 and glucocorticoids as effectors of the resolution of inflammation , 2009, Nature Reviews Immunology.

[6]  T. Wynn,et al.  Protective and pathogenic functions of macrophage subsets , 2011, Nature Reviews Immunology.

[7]  C. Restall,et al.  Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix. , 2005, Molecular cancer research : MCR.

[8]  G. Sethi,et al.  Annexin-A1 Regulates MicroRNA-26b* and MicroRNA-562 to Directly Target NF-κB and Angiogenesis in Breast Cancer Cells , 2014, PloS one.

[9]  Shazib Pervaiz,et al.  Annexin 1: the new face of an old molecule , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  Jeffrey W. Pollard,et al.  Macrophage Diversity Enhances Tumor Progression and Metastasis , 2010, Cell.

[11]  P. Allavena,et al.  Cancer related inflammation: the macrophage connection. , 2008, Cancer letters.

[12]  Alberto Mantovani,et al.  Macrophage activation and polarization. , 2008, Frontiers in bioscience : a journal and virtual library.

[13]  G. Sethi,et al.  ANXA1 inhibits miRNA-196a in a negative feedback loop through NF-kB and c-Myc to reduce breast cancer proliferation , 2016, Oncotarget.

[14]  Noam Brown,et al.  The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies , 2002, The Journal of pathology.

[15]  Philip M Murphy,et al.  Formyl-peptide receptors revisited. , 2002, Trends in immunology.

[16]  G. Sethi,et al.  Annexin-A1 controls an ERK-RhoA-NFκB activation loop in breast cancer cells. , 2015, Biochemical and biophysical research communications.

[17]  H. Varmus,et al.  Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer , 2000, Oncogene.

[18]  P R Taylor,et al.  Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. , 2000, Cancer research.

[19]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[20]  D. Ye,et al.  Pleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2 , 2011, Oncogene.

[21]  C. Reutelingsperger,et al.  Definition of a Novel Pathway Centered on Lysophosphatidic Acid To Recruit Monocytes during the Resolution Phase of Tissue Inflammation , 2015, The Journal of Immunology.

[22]  Wei-Qiang Gao,et al.  CCL5-Mediated Th2 Immune Polarization Promotes Metastasis in Luminal Breast Cancer. , 2015, Cancer research.

[23]  A. Ben-Baruch,et al.  Host microenvironment in breast cancer development: Inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor–microenvironment interactions , 2002, Breast Cancer Research.

[24]  S. Leow,et al.  Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-κB: implication in breast cancer metastasis , 2011, Oncogene.

[25]  R. Flower,et al.  Lipocortin-1: cellular mechanisms and clinical relevance. , 1994, Trends in pharmacological sciences.

[26]  Fang Liu,et al.  Overexpression of annexin 1 in pancreatic cancer and its clinical significance. , 2004, World journal of gastroenterology.

[27]  X. Bian,et al.  Annexin 1 released by necrotic human glioblastoma cells stimulates tumor cell growth through the formyl peptide receptor 1. , 2011, The American journal of pathology.

[28]  R. Hancock,et al.  Host Defense Peptide LL-37 Selectively Reduces Proinflammatory Macrophage Responses , 2011, The Journal of Immunology.

[29]  T. Gajewski,et al.  Immune suppression in the tumor microenvironment. , 2006, Journal of immunotherapy.

[30]  V. Gerke,et al.  A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. , 2000, Molecular cell.

[31]  S. Gordon,et al.  Alternative activation of macrophages: mechanism and functions. , 2010, Immunity.

[32]  S. Mussunoor,et al.  The role of annexins in tumour development and progression , 2008, The Journal of pathology.

[33]  M. Perretti,et al.  Annexin 1: an endogenous anti-inflammatory protein. , 2003, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[34]  T. Hagemann,et al.  The tumor microenvironment at a glance , 2012, Journal of Cell Science.

[35]  M. Hickey,et al.  Annexin A1 and the regulation of innate and adaptive immunity , 2012, Front. Immun..

[36]  P. Taylor,et al.  Tissue-resident macrophages , 2013, Nature Immunology.

[37]  M. Schuliga,et al.  Annexin‐1 signals mitogen‐stimulated breast tumor cell proliferation by activation of the formyl peptide receptors (FPRs) 1 and 2 , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  Marc Parmentier,et al.  International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family , 2009, Pharmacological Reviews.

[39]  I. Tohnai,et al.  M2-polarized macrophages contribute to neovasculogenesis, leading to relapse of oral cancer following radiation , 2016, Scientific Reports.

[40]  K. Kumamoto,et al.  Up-regulated Annexin A1 expression in gastrointestinal cancer is associated with cancer invasion and lymph node metastasis. , 2011, Experimental and therapeutic medicine.

[41]  B. Rigas,et al.  Annexin 1 induced by anti-inflammatory drugs binds to NF-kappaB and inhibits its activation: anticancer effects in vitro and in vivo. , 2010, Cancer research.

[42]  A. Mantovani,et al.  Differential regulation of chemokine production by Fcγ receptor engagement in human monocytes: association of CCL1 with a distinct form of M2 monocyte activation (M2b, Type 2) , 2006, Journal of leukocyte biology.

[43]  E. Solito,et al.  Annexin 1: more than an anti-phospholipase protein , 2004, Inflammation Research.

[44]  N. Skelton,et al.  Distinct but overlapping epitopes for the interaction of a CC-chemokine with CCR1, CCR3 and CCR5. , 1997, Biochemistry.

[45]  Alberto Mantovani,et al.  Macrophage plasticity and polarization: in vivo veritas. , 2012, The Journal of clinical investigation.

[46]  G. J. Blackwell,et al.  Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids , 1980, Nature.